EMEA-000694-PIP02-14-M02

Key facts

Invented name
Forxiga
Active substance
dapagliflozin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0302/2017
PIP number
EMEA-000694-PIP02-14-M02
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral dosage form
Condition(s) / indication(s)
Treatment of type 1 diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
AstraZeneca AB

Tel. +46 8553 27591
E-mail: paediatrics@astrazeneca.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating